Dr. Boris Reznik, MD

Dr. Reznik practices at Adventist Health Hanford in Hanford, California, part of Adventist Health.

Dr. Reznik's NPI, 1710087846, was assigned on September 25, 2006. Dr. Reznik graduated from Russian State Medical University in 1980. Dr. Reznik holds California license A91193.

Dr. Reznik's primary practice is Adventist Health Hanford, at 115 Mall Drive, Hanford, CA 93230 in Kings County. The practice phone is (559) 582-9000.

Dr. Reznik's primary practice is Adventist Health Hanford in Hanford, California, part of Adventist Health. Dr. Reznik is also affiliated with Adventist Health Tulare. The medical group on file is Adventist Health Community Care-Hanford. Dmand AI also links Dr. Reznik to 1 more hospital, 1 rural health clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reznik practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Reznik's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Reznik is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Reznik's licenses on file in 3 states: California, Utah and New Mexico.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hepatitis c among the conditions Dr. Reznik treats.

CMS data shows 279 Medicare services from Dr. Reznik across 9 procedure codes in 2024, for 209 Medicare patients. Medicare paid $30,009 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 209 Medicare patients who saw Dr. Reznik in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 69% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reznik's median patient age at 54, with 63% women.

In 2024, Dr. Reznik wrote 579 Medicare Part D claims for 194 patients. 57% of them were for generic drugs. CMS names the drug for 402 of them, across 17 drugs with 11 or more claims each, at $342,135 in total drug cost. In 2023, CMS named 483 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Reznik for performance year 2024, reported as part of a group. CMS counts 197 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reznik, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Reznik, published from 2014 to 2019. The most frequent topics are Gene Expression Regulation, Histones and RNA, Messenger.

CMS Open Payments shows 443 general payments to Dr. Reznik from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $5,459.

Dr. Reznik graduated from Russian State Medical University in 1980.

Dr. Reznik is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.